Healthcare entity
Every one of those 1 sits in a single category, funding. Psyence Biomedical Ltd. is most often covered alongside Ibogaine, which appears in 1 of these 1 story. Psyence Biomedical Ltd. appears in 1 tracked Healthcare story from February 21, 2026.
Last mentioned: Feb 21, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, funding. Psyence Biomedical Ltd. is most often covered alongside Ibogaine, which appears in 1 of these 1 story. Psyence Biomedical Ltd. appears in 1 tracked Healthcare story from February 21, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Psyence Biomedical Ltd.. Shared-story counts are live from our verified record — not editorial picks.
Valuation Period
Expected timeframe for determining the fair market value of the equity investment.
Option Exercised
PsyLabs officially triggers the put option, requiring an equity investment from PBM.
Put Option Established
Psyence BioMed and PsyLabs enter into a strategic put option agreement.
Psyence Biomedical Ltd. (Nasdaq: PBM) has confirmed a strategic equity investment in PsyLabs following the exercise of a previously established put option. This move deepens the integration between the biopharmaceutical developer and its primary manufacturer of pharmaceutical-grade psychedelic compounds.
Source: CBJ (ca) · manilatimes.net
Psyence Biomedical Ltd. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
